Enrollment open • Combination therapy
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor) • PGR (Progesterone receptor)
|
HER-2 negative • PGR expression
|
albumin-bound paclitaxel • Yidafan (ivonescimab) • ligufalimab (AK117)